Myth or Truth: The Glass Forming Ability Class III Drugs Will Always Form Single-Phase Homogenous Amorphous Solid Dispersion Formulations
Open Access
- 14 October 2019
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 11 (10) , 529
Abstract
The physical stability of amorphous solid dispersions (ASD) of active pharmaceutical ingredients (APIs) of high glass forming ability (GFA class III) is generally expected to be high among the scientific community. In this study, the ASD of ten-selected class III APIs with the two polymers, PVPVA 64 and HPMC-E5, have been prepared by spray-drying, film-casting, and their amorphicity at T0 was investigated by modulated differential scanning calorimetry and powder X-ray diffraction. It was witnessed that only five out of ten APIs form good quality amorphous solid dispersions with no phase separation and zero crystalline content, immediately after the preparation and drying process. Hence, it was further established that the classification of an API as GFA class III does not guarantee the formulation of single phase amorphous solid dispersions.Keywords
This publication has 47 references indexed in Scilit:
- Toward In Silico Prediction of Glass-Forming Ability from Molecular Structure Alone: A Screening Tool in Early Drug DevelopmentMolecular Pharmaceutics, 2011
- A Classification System to Assess the Crystallization Tendency of Organic Molecules from Undercooled MeltsJournal of Pharmaceutical Sciences, 2010
- Crystallization Tendency of Active Pharmaceutical Ingredients Following Rapid Solvent Evaporation—Classification and Comparison with Crystallization Tendency from Under cooled MeltsJournal of Pharmaceutical Sciences, 2010
- Review: physical chemistry of solid dispersionsJournal of Pharmacy and Pharmacology, 2009
- Review: physical chemistry of solid dispersionsJournal of Pharmacy and Pharmacology, 2009
- Differences in the interaction between aryl propionic acid derivatives and poly(vinylpyrrolidone) K30: A multi-methodological approachJournal of Pharmaceutical Sciences, 2009
- Strong CH⋅⋅⋅Halide Hydrogen Bonds from 1,2,3‐Triazoles Quantified Using Pre‐Organized and Shape‐Persistent TriazolophanesChemphyschem, 2009
- Role of Molecular Interaction in Stability of Celecoxib−PVP Amorphous SystemsMolecular Pharmaceutics, 2005
- Very Strong C−H···O, N−H···O, and O−H···O Hydrogen Bonds Involving a Cyclic PhosphateJournal of the American Chemical Society, 2001
- Ideal copolymers and the second‐order transitions of synthetic rubbers. i. non‐crystalline copolymersJournal of Chemical Technology & Biotechnology, 1952